Zevra Therapeutics, Inc. Common Stock (ZVRA) Stock Price

ZVRAStock
$12.04+23.41%52W
Market Cap$714.98M
P/E8.32x
PEG Ratio10.67
Div yield
Beta0.96

ZVRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)23.44%
Price vs S&P 500 (4W)16.68%
PEG Ratio10.67
VGM Score61.43
P/E Ratio (Annual)8.32x

ZVRA Earnings Surprise History

Q2 25-0.06est. 1.38
Q3 25-0.01est. -0.02
Q4 250.19est. 0.04
Q1 260.18est. 0.08
Q2 260.25est. 0.16

ZVRA Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.27
4.27
4.27
4.27

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ZVRAZevra Therapeutics, Inc. Common Stock
CBB$12.04
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Zevra Therapeutics, Inc. Common Stock

Zevra Therapeutics is a biopharmaceutical company focused on developing and commercializing transformational therapies for rare diseases with limited or no existing treatment options. The company employs data-driven strategies to overcome complex drug development challenges and accelerate the delivery of novel therapeutics to underserved patient populations.